Insights

Expanding Oncology Portfolio QIAGEN has been expanding its oncology portfolio through strategic partnerships, such as alliances for minimal residual disease (MRD) testing. This move positions the company well for sales opportunities in the personalized cancer care sector.

Digital PCR Oncology Research The recent partnership with ID Solutions in the digital PCR oncology research field enhances QIAGEN's product offerings. This collaboration opens doors for sales of dPCR assays for oncology research applications, fostering potential revenue growth.

Companion Diagnostic Development QIAGEN's partnership with Foresight Diagnostics to develop companion diagnostic kits for lymphoma showcases the company's commitment to advancing diagnostic solutions. This collaboration creates a new avenue for sales of diagnostic kits in the hematological malignancies sector.

Bioinformatics Software Expertise With a focus on bioinformatics software and knowledge bases to interpret data for actionable insights, QIAGEN stands out as a leader in providing comprehensive molecular insights solutions. Exploiting this software expertise can lead to potential sales opportunities in data analysis tools for customers.

Global Molecular Diagnostics Reach Servicing over 500,000 customers worldwide in Molecular Diagnostics, QIAGEN has established a strong global presence. Leveraging this extensive customer base, the company can explore cross-selling and up-selling opportunities to drive sales growth.

Similar companies to QIAGEN

QIAGEN Tech Stack

QIAGEN uses 8 technology products and services including Web Components, Google Hosted Libraries, MariaDB, and more. Explore QIAGEN's tech stack below.

Web Components
Application Development & Management
Google Hosted Libraries
Content Delivery Network
MariaDB
Database
PostgreSQL
Database
Veeva Vault
Enterprise Content Management
UPS
Logistics
Ruby
Programming Languages
Java
Programming Languages

Media & News

QIAGEN's Email Address Formats

QIAGEN uses at least 1 format(s):

QIAGEN Email Formats	Example	Percentage
First.Last@qiagen.com	John.Doe@qiagen.com	96%
Last.F@qiagen.com	Doe.J@qiagen.com	2%
Last.First@qiagen.com	Doe.John@qiagen.com	1%
First.Middle@qiagen.com	John.Michael@qiagen.com	1%

Frequently Asked Questions

Where is QIAGEN's headquarters located?

QIAGEN's main headquarters is located at Hulsterweg 82, Venlo, Limburg 5912 PL, NL. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is QIAGEN's phone number?

You can contact QIAGEN's main corporate office by phone at

+49-7771-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is QIAGEN's stock symbol?

QIAGEN is a publicly traded company; the company's stock symbol is QGEN.

What is QIAGEN's official website and social media links?

QIAGEN's official website is qiagen.com and has social profiles on LinkedIn Crunchbase.

How much revenue does QIAGEN generate?

As of June 2025, QIAGEN's annual revenue reached $5B.

What is QIAGEN's SIC code NAICS code?

QIAGEN's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 424210 - Drugs and Druggists' Sundries Merchant Wholesalers.

How many employees does QIAGEN have currently?

As of June 2025, QIAGEN has approximately 5.5K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: T. B.Chief Executive Officer: R. S.Chief Information Security Officer: D. S.. Explore QIAGEN's employee directory with LeadIQ.

What industry does QIAGEN belong to?

QIAGEN operates in the Biotechnology Research industry.

What technology does QIAGEN use?

QIAGEN's tech stack includes Web ComponentsGoogle Hosted LibrariesMariaDBPostgreSQLVeeva VaultUPSRubyJava.

What is QIAGEN's email format?

QIAGEN's email format typically follows the pattern of . Find more QIAGEN email formats with LeadIQ.

QIAGEN

Biotechnology ResearchNetherlands5001-10000 Employees

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. 

QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). 

As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.